查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2040333

神經病學領域人工智慧市場規模、佔有率和趨勢分析報告：按應用、神經系統疾病、組件、最終用途、地區和細分市場預測（2026-2033 年）

AI In Neurology Market Size, Share & Trends Analysis Report By Application, By Neurological Condition, By Components, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

神經學領域人工智慧市場概述

2025年全球神經學領域的人工智慧市場規模估計為7.6億美元，預計到2033年將達到45億美元。

預計從 2026 年到 2033 年，該市場將以 24.9% 的複合年成長率成長。全球神經系統疾病盛行率的上升，以及人們對早期診斷和精準醫療日益成長的興趣，是市場擴張的主要驅動力。

此外，遠端監控解決方案的日益普及，以及政府的支援措施和法規結構的發展，進一步加速了人工智慧技術融入神經醫學，從而提高了診斷準確性，改善了患者預後，提高了臨床工作流程效率。

以下各節概述了市場成長的關鍵促進因素，重點關注神經系統疾病的日益普遍、早期診斷的必要性以及政府和監管機構的支持。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：神經病學領域的人工智慧市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 個案研究的啟示
  • 神經學領域的人工智慧市場分析工具

第4章：神經病學領域的人工智慧市場：按組件分類的估算和趨勢分析

  • 全球神經病學領域人工智慧市場：基於組件的波動分析
  • 全球神經病學人工智慧市場：基於組件的規模和趨勢分析，2021-2033年
  • 軟體
  • 人工智慧設備
  • 服務

第5章：神經病學領域人工智慧市場：基於應用的估算和趨勢分析

  • 全球神經病學領域人工智慧市場：基於應用的波動分析
  • 全球神經病學人工智慧市場：基於應用的規模和趨勢分析（2021-2033年）
  • 神經影像學
  • 臨床決策支援系統（CDSS）
  • 疾病進展監測
  • 藥物發現與開發
  • 腦機介面（BCI）和神經技術
  • 復健和治療管理
  • 其他

第6章：神經病學領域的人工智慧市場：神經系統疾病的估算與趨勢分析

  • 人工智慧在全球神經病學領域的市場：神經系統疾病波動分析
  • 2021-2033 年全球 AI 市場規模及神經學領域趨勢分析（依神經系統疾病分類）。
  • 中風
  • 阿茲海默症和失智症
  • 帕金森氏症
  • 癲癇
  • 多發性硬化症
  • 創傷性腦損傷（TBI）
  • 腦腫瘤
  • 其他

第7章：神經病學領域的人工智慧市場：按最終用途分類的估算和趨勢分析

  • 全球神經病學人工智慧市場：按最終用途分類的波動分析
  • 全球神經病學領域人工智慧市場：最終用戶規模和趨勢分析（2021-2033年）
  • 醫院和診所
  • 神經科科診所
  • 研究機構和學術機構
  • 製藥和生物技術公司
  • 其他

第8章：神經病學領域的人工智慧市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • GE Healthcare
    • Cortechs.ai
    • Viz.ai
    • RapidAI（trademarks of iSchemaView, Inc）
    • Aidoc
    • Brainomix
    • Avicenna.AI
    • Natus
    • Hyperfine
    • PERSYST DEVELOPMENT LLC
    • Ceribell, Inc.
    • Empatica Inc.
    • Koninklijke Philips NV
    • Siemens Healthiness
Product Code: GVR-4-68040-894-7

AI in Neurology Market Summary

The global AI in neurology market size was estimated at USD 760.0 million in 2025 and is projected to reach USD 4.5 billion by 2033, growing at a CAGR of 24.9% from 2026 to 2033. The rising global prevalence of neurological disorders, along with the increasing focus on early diagnosis and precision medicine, are among the key factors driving market expansion.

In addition, growing adoption of remote monitoring solutions, coupled with supportive government initiatives and evolving regulatory frameworks, further drives the integration of AI technologies into neurological care, enhancing diagnostic accuracy, improving patient outcomes, and streamlining clinical workflows.

The section below outlines the key factors driving market growth, highlighting the rising prevalence of neurological disorders, the need for early diagnosis, and support from government and regulatory bodies.

Global AI in Neurology Market Report Segmentation

This report forecasts revenue growth and provides, at global, regional, and country levels, an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global AI in neurology market report based on component, application, neurological condition, end use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • AI-enabled Devices
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Neuroimaging & Diagnostics
  • Clinical Decision Support Systems (CDSS)
  • Disease Progression Monitoring
  • Brain-Computer Interface (BCI) & Neurotechnology
  • Rehabilitation & Therapy Management
  • Drug Discovery & Development
  • Others
  • Neurological Condition Outlook (Revenue, USD Million, 2021 - 2033)
  • Stroke
  • Alzheimer's Disease & Dementia
  • Parkinson's Disease
  • Epilepsy
  • Multiple Sclerosis
  • Traumatic Brain Injury (TBI)
  • Brain Tumors
  • Others
  • End use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Neurology Centers
  • Research & Academic Institutions
  • Pharmaceutical & Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Application Segment
    • 1.2.3. Neurological Condition Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. AI in Neurology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Study Insights
  • 3.4. AI in Neurology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. AI in Neurology Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI in Neurology Market Component Movement Analysis
  • 4.3. Global AI in Neurology Market Size & Trend Analysis, by Component, 2021 - 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. AI-enabled Devices
    • 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. AI in Neurology Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI in Neurology Market Application Movement Analysis
  • 5.3. Global AI in Neurology Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
  • 5.4. Neuroimaging & Diagnostics
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Clinical Decision Support Systems (CDSS)
    • 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Disease Progression Monitoring
    • 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Drug Discovery & Development
    • 5.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Brain-Computer Interface (BCI) & Neurotechnology
    • 5.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.9. Rehabilitation & Therapy Management
    • 5.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. AI in Neurology Market: Neurological Condition Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI in Neurology Market: Neurological Condition Movement Analysis
  • 6.3. Global AI in Neurology Market Size & Trend Analysis, by Neurological Condition, 2021 - 2033 (USD Million)
  • 6.4. Stroke
    • 6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Alzheimer's Disease & Dementia
    • 6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Parkinson's Disease
    • 6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Epilepsy
    • 6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Multiple Sclerosis
    • 6.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.9. Traumatic Brain Injury (TBI)
    • 6.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.10. Brain Tumors
    • 6.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.11. Others
    • 6.11.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. AI in Neurology Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global AI in Neurology Market: End Use Movement Analysis
  • 7.3. Global AI in Neurology Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Neurology Centers
    • 7.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Research & Academic Institutions
    • 7.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Pharmaceutical & Biotechnology Companies
    • 7.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. AI in Neurology Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Company Profiles/Listing
    • 9.4.1. GE Healthcare
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Technology type benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Cortechs.ai
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Technology type benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Viz.ai
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Technology type benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. RapidAI (trademarks of iSchemaView, Inc)
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Technology type benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Aidoc
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Technology type benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Brainomix
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Technology type benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Avicenna.AI
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Technology type benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Natus
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Technology type benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Hyperfine
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Technology type benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. PERSYST DEVELOPMENT LLC
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Technology type benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Ceribell, Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Technology type benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Empatica Inc.
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Technology type benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Koninklijke Philips N.V.
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Technology type benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Siemens Healthiness
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Technology type benchmarking
      • 9.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America AI in neurology market, by region, 2021 - 2033 (USD Million)
  • Table 4 North America AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 7 North America AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 11 U.S. AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 15 Canada AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 19 Mexico AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe AI in neurology market, by region, 2021 - 2033 (USD Million)
  • Table 21 Europe AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 22 Europe AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 24 Europe AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Germany AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 26 Germany AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 27 Germany AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 28 Germany AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 30 France AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 31 France AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 32 France AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 33 UK AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 34 UK AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 35 UK AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 36 UK AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Italy AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 38 Italy AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 39 Italy AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 40 Italy AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Spain AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 42 Spain AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 43 Spain AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 44 Spain AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Denmark AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 46 Denmark AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 47 Denmark AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 48 Denmark AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Sweden AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 50 Sweden AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 51 Sweden AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 52 Sweden AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Norway AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 54 Norway AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 55 Norway AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 56 Norway AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific AI in neurology market, by region, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 62 China AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 63 China AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 64 China AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 65 China AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Japan AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 67 Japan AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 68 Japan AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 69 Japan AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 70 India AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 71 India AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 72 India AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 73 India AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 74 South Korea AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 75 South Korea AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 76 South Korea AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 77 South Korea AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 78 Australia AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 79 Australia AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 80 Australia AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 81 Australia AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Thailand AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 83 Thailand AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 84 Thailand AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 85 Thailand AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Latin America AI in neurology market, by region, 2021 - 2033 (USD Million)
  • Table 87 Latin America AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 88 Latin America AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 89 Latin America AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 90 Latin America AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 91 Brazil AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 92 Brazil AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 93 Brazil AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 94 Brazil AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Argentina AI in neurology market, by region, 2021 - 2033 (USD Million)
  • Table 96 Argentina AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 97 Argentina AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 98 Argentina AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 99 Argentina AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 100 MEA AI in neurology market, by region, 2021 - 2033 (USD Million)
  • Table 101 MEA AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 102 MEA AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 103 MEA AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 104 MEA AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 105 South Africa AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 106 South Africa AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 107 South Africa AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 108 South Africa AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 113 UAE AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 114 UAE AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 115 UAE AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 116 UAE AI in neurology market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Kuwait AI in neurology market, by component, 2021 - 2033 (USD Million)
  • Table 118 Kuwait AI in neurology market, by application, 2021 - 2033 (USD Million)
  • Table 119 Kuwait AI in neurology market, by neurological condition, 2021 - 2033 (USD Million)
  • Table 120 Kuwait AI in neurology market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 AI in neurology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 AI in neurology market snapshot
  • Fig. 7 AI in neurology market segment snapshot (part 1)
  • Fig. 8 AI in neurology market segment snapshot (part 2)
  • Fig. 9 AI in neurology market competitive landscape snapshot
  • Fig. 10 Market research process
  • Fig. 11 Parent market outlook (USD Billion) (2025)
  • Fig. 12 AI in neurology market dynamics
  • Fig. 13 AI in neurology market: Porter's five forces analysis
  • Fig. 14 AI in neurology market: PESTLE analysis
  • Fig. 15 AI in neurology market, component outlook key takeaways (USD million)
  • Fig. 16 AI in neurology market: component movement analysis, 2025 & 2033 (USD Million)
  • Fig. 17 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 AI-enabled devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 AI in neurology market, application outlook key takeaways (USD Million)
  • Fig. 21 AI in neurology market: application movement analysis, 2025 & 2033 (USD Million)
  • Fig. 22 Neuroimaging & diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Clinical decision support systems (CDSS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Disease Progression Monitoring market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Drug discovery & development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Brain-computer interface (BCI) & neurotechnology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rehabilitation & therapy management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 AI in neurology market, neurological condition outlook key takeaways (USD Million)
  • Fig. 30 AI in neurology market: neurological condition movement analysis, 2025 & 2033 (USD Million)
  • Fig. 31 Stroke market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Alzheimer's disease & dementia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Parkinson's disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Epilepsy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Multiple Sclerosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Traumatic brain injury (TBI) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Brain tumors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 AI in neurology market, end use outlook key takeaways (USD Million)
  • Fig. 40 AI in neurology market: end use analysis, 2025 & 2033 (USD Million)
  • Fig. 41 Hospitals & clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Neurology centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Research & academic institutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Artificial intelligence in Neurology Market: Regional outlook
  • Fig. 48 North America AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 U.S AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Canada AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Mexico AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 55 Europe AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Germany AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 France AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Italy AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Spain AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Norway AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 72 Asia Pacific AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Australia AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 85 Latin America AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Brazil AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Argentina AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 90 MEA AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Africa AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Saudi Arabia AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Kuwait AI in neurology market, 2021 - 2033 (USD Million)
  • Fig. 99 Company Categorization
  • Fig. 100 Company market position/share analysis, 2025
  • Fig. 101 Strategic Framework